Podcasts by CCO Oncology Podcast
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
Further podcasts by Clinical Care Options
Podcast on the topic Kurse
All episodes
New Evidence With BTK Inhibitor Therapy in CLL and MCL From SOHO 2023 from 2023-12-12T21:14:12.060914
In this episode, Catherine C. Coombs, MD, MS, and Toby Eyre, MBChB, MD, discuss key trials presented at SOHO 2023 evaluating the use of BTK inhibitors in chronic lymphocytic leukemia (CLL) and m...
Listen
Improving Care for Black Patients With Endometrial Cancer from 2023-12-12T21:14:12.055368
In this episode, Dr Leslie Boyd and Adrienne Moore, a patient advocate and endometrial cancer survivor, discuss how healthcare professionals can partner with Black patients to improve the diagno...
Listen
Expert Insights and Considerations for Precision Care With HER3-Targeted Agents in NSCLC and Breast Cancer from 2023-12-12T21:14:12.052501
In this episode, Aakash Desai, MD; Narjust Florez, MD; and Paolo Tarantino, MD, discuss the biologic rationale and clinical development of agents targeting HER3 for the treatment of breast and l...
Listen
Expert Insight on Seminal New Clinical Trial Data Presented at the 2023 IGCS Conference Informing Treatment for Endometrial, Ovarian, and Cervical Cancers from 2023-12-12T21:14:12.044457
In this episode, Brian Slomovitz, MD, MS, FACOG, and Keiichi Fujiwara, MD, PhD, share their thoughts and opinions on seminal data presented at the 2023 IGCS annual meeting for endometrial, ovari...
Listen
Novel Emerging Investigational Treatment Strategies for Patients With Myelofibrosis from 2023-11-30T14:09:57
In this episode, Jacqueline S. Garcia, MD, discusses novel agents and strategies in clinical trial development for treating patients with myelofibrosis, including:
- Navitoclax (BCL-XL/... Listen
A Year in Review and a Look to the Future: BTKi in CLL and MCL from 2023-11-20T05:00
In this episode, Ana Marin-Niebla, MD, PhD, and Stephan Stilgenbauer, MD, discuss key trial data on the use of BTK inhibitors in CLL and MCL throughout the past year, how these studies have impa...
Listen
Expert Insight on Key Updates and New Clinical Trial Data From the ESMO 2023 Congress Informing Treatment for Endometrial, Ovarian, and Cervical Cancers from 2023-11-17T19:36:09
In this episode, Isabelle Ray-Coquard, MD, PhD, and Ana Oaknin, MD, PhD, provide expert insights on new clinical trial data presented at the 2023 ESMO annual congress for endometrial, ovarian, a...
Listen
Expert Insight on Key Updates and New Clinical Trial Data From the ESGO 2023 Congress Informing Treatment for Cervical, Ovarian, and Endometrial Cancers from 2023-10-13T04:00
In this episode, Domenica Lorusso, MD, PhD, and Alexandra Leary, MD, PhD, provide expert insights on key updates and new clinical trial data presented at the ESGO 2023 Congress for cervical, end...
Listen
New Evidence With BTK Inhibitor Therapy in MCL From ICML 2023 from 2023-08-17T20:20:17
In this episode, Catherine C. Coombs, MD, and Toby Eyre, MBChB, MD, discuss key trials presented at ICML 2023 evaluating the use of BTK inhibitors in mantle cell lymphoma (MCL). The discussion i...
Listen
New Evidence With BTK Inhibitor Therapy in CLL From EHA 2023 from 2023-07-28T04:00
In this episode, Catherine C. Coombs, MD, MS, and Toby Eyre, MBChB, MD, discuss key trials presented at EHA 2023 evaluating the use of BTK inhibitors in chronic lymphocytic leukemia (CLL). The d...
Listen
Expert Insight on Key Updates and New Clinical Trial Data From the 2023 ASCO Annual Meeting, Informing Treatment for Cervical, Ovarian, and Endometrial Cancers from 2023-06-22T13:45:43
In this episode, Kathleen Moore, MD, MS, and Nicoletta Colombo, MD, PhD, provide expert insights on key updates and new clinical trial data presented at the 2023 ASCO Annual Meeting for cervical...
Listen
New Advances in Relapsed/Refractory Multiple Myeloma: Frequently Asked Questions on Current and Emerging Treatments from 2022-05-04T05:02:29.013417
In this episode, Natalie S. Callander, MD, and Shaji Kumar, MD, answer audience questions from a live CCO Webinar on relapsed/refractory myeloma regarding challenges in treating patients in this...
Listen
FAQ on New Therapeutic Developments in Relapsed/Refractory Multiple Myeloma from 2022-05-04T05:02:29.010987
In this episode, Jesús F. San-Miguel, MD, PhD; Paula Rodriguez-Otero, MD, PhD; and Prof. Dr. med. Katja Weisel answer questions focused on current and emerging therapies for early and late rela...
Listen
Practical Application of Immuno-Oncology in RCC: Expert Discussion of Second-line Therapy and Beyond from 2022-05-04T05:02:29.007822
In this episode, an expert medical oncology panel, led by Elizabeth R. Plimack, MD, with Brian A. Costello, MD, and Martin H. Voss, MD, discusses current best practices for the second-line treat...
Listen
Biomarkers in Ovarian Cancer: Expert Discussion of BRCA Testing and Beyond from 2022-05-04T05:02:28.981983
Listen to Prof Nicoletta Colombo and Bradley J. Monk, MD, FACS, FACOG, discuss current best practices for biomarker testing for your patients with advanced ovarian cancer.
In this episode,...
Listen
Biomarkers in Ovarian Cancer: Expert Discussion of Options for First-line Maintenance Therapy from 2022-05-04T05:02:28.979136
In this episode, Isabelle Ray Coquard, MD, PhD and Bradley J. Monk, MD, FACS, FACOG, discuss current first-line maintenance therapy options for patients with advanced ovarian cancer.
Developments in Acute Leukemias: Expert Answers to Clinician Questions from 2022-05-04T05:02:28.973967
In this episode, David Marks, MD, PhD, and Stéphane de Botton, MD, answer questions from clinicians on management pearls for patients with acute leukemias. Topics include:
- MRD in the ... Listen
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain from 2022-05-04T05:02:28.920611
In this episode, Félix Guerrero Ramos, MD, PhD, FEBU, and Óscar Rodríguez-Faba, MD, discuss in Spanish the latest immuno-oncology developments in the treatment of urothelial cancer.
Prese...
Listen
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the United States from 2022-05-04T05:02:28.906430
In this episode, Petros Grivas, MD, PhD, and Jonathan E. Rosenberg, MD, discuss key data on immune checkpoint inhibitors for urothelial carcinoma informing their clinical p... Listen
Expert Answers to Questions on Contemporary Management of Hemophilia A from 2022-05-04T05:02:28.900113In this episode, Michael Callaghan, MD; Miguel A. Escobar, MD; and Rebecca Kruse-Jarres, MD, MPH, answer questions from a clinician audience on topics related to hemophilia management including:... Listen
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Italy from 2022-05-04T05:02:28.832608In this episode, Guiseppe Procopio, MD, and Cora N. Sternberg, MD, FACP, discuss in Italian the latest immuno-oncology developments in the treatment of urothelial cancer. Presenters: ... Listen
Expert Insights on Key Data From ASH 2020 on Myelodysplastic Syndromes and Myeloproliferative Neoplasms from 2022-05-04T05:02:28.829788In this episode, Amy E. DeZern, MD, MHS, and Srdan Verstovsek, MD, provide medical oncology and hematology perspectives on new data from ASH 2020 in MDS and MPNs, with topics including:
Expert Answers to Questions on PARP Inhibition for Prostate Cancer from 2022-05-04T05:02:28.798300In this episode, Charles J. Ryan, MD, and Neal D. Shore, MD, FACS, answer questions from a healthcare professional audience on topics related to prostate cancer and PARP inhibition including: Listen
Expert Insight on Key Data From SGO 2021 Informing Treatment for Endometrial and Ovarian Cancer from 2022-05-04T05:02:28.795494In this episode, Jubilee Brown, MD, and Ursula Matulonis, MD, provide expert perspectives on new data from SGO 2021 presented for endometrial and ovarian cancer including:
Managing Toxicities Associated With FGFR Inhibitors in Urothelial Cancer and Beyond from 2022-05-04T05:02:28.786259In this episode, Ignacio Durán, MD, PhD, and Alison Birtle, MD, FRCP, FRCR, discuss toxicities associated with FGFR inhibitors used in the treatment of urothelial cancer and other malignancies ... Listen
CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Expert Answers to Clinician Questions from 2022-05-04T05:02:28.635850In this episode, Javier Cortes, MD, PhD; Stephen R. D. Johnston, MA, FRCP, PhD; and Sara Tolaney, MD, MPH, answer questions from an audience of healthcare professionals on topics related to lev... Listen
Expert Answers to HCP Questions on Androgen Deprivation Therapy for Prostate Cancer from 2022-05-04T05:02:28.613675In this episode, Daniel W. Lin, MD; Alicia K. Morgans, MD, MPH; and David F. Penson, MD, answer audience questions from a live CCO webinar focused on current best practices and emerging strategi... Listen
Rationale for NTRK Testing in Patients With Cancer from 2022-05-04T05:02:28.610402In this episode, George D. Demetri, MD, and Alexander Drilon, MD, discuss the biologic rationale behind testing for NTRK fusions in patients with various solid tumors, along with clinical... Listen
Counseling Patients and Caregivers on Prophylaxis Therapy for Severe Hemophilia A from 2022-05-04T05:02:28.606899In this episode, listen to Guy A. Young, MD, as he counsels a teenage patient with severe hemophilia A and the patient’s mother on various available treatment options and strategies for optimizi... Listen
Role of TKIs in Nonadipocytic Soft Tissue Sarcoma and Advanced Osteosarcoma from 2022-05-04T05:02:28.587829In this podcast episode, Jean-Yves Blay, MD, PhD, and Robin L. Jones, BSc, MBBS, MRCP, MD(Res), discuss the most important clinical trial data on leveraging TKIs as monotherapy and in combinatio... Listen
Overcoming Acquired Resistance With Second-Generation TRK Inhibitors from 2022-05-04T05:02:28.584369In this podcast episode, George D. Demetri, MD, and Alexander Drilon, MD, discuss emerging data on the efficacy, safety, and clinical role of second-generation TRK inhibitors that can overcome a... Listen
Precision Medicine for aTTP: Expert Answers to Your Questions from 2022-05-04T05:02:28.521112In this episode, Ara Metjian, MD; Paul Coppo, MD, PhD; and Marshal Mazepa, MD, answer questions from an audience of healthcare professionals on topics related to the management of acquired throm... Listen
Expert Insights on Advances in Immune Thrombocytopenia from 2022-05-04T05:02:28.509898In this episode, Keith R. McCrae, MD; Nichola Cooper, MD; and Rachael Grace, MD, MMSc,provide expert insights on immune thrombocytopenia management, along with addressing frequently asked questi... Listen
Evolving Treatment Landscape With Regorafenib and TAS-102 in Metastatic Colorectal Cancer from 2022-05-04T05:02:28.424126In this episode, Nilofer S. Azad, MD, and Kanwal Raghav, MD, discuss current and emerging uses of regorafenib and TAS-102 in later-line treatment of patients with mCRC, with topics including: Listen
Targeting TIGIT: Understanding New Approaches for Inhibiting the Immune Checkpoint Pathway from 2022-05-04T05:02:28.421059In this episode, Jyoti D. Patel, MD, and Diwakar Davar, MD, discuss several studies investigating agents targeting TIGIT, an emerging immune checkpoint target with promising early-phase clinical... Listen
Inclusive Healthcare for Transgender Individuals: Insights From a Healthcare Professional’s Transition Experience from 2022-05-04T05:02:28.415882In this episode, Pharmacist Olivia Buckoski shares her experience undergoing medical and social transition and offers advice from the perspective of both a transgender person and healthcare prof... Listen
Anti-TIGIT Therapy: Overview of Current Clinical Evidence and Key Ongoing Trials from 2022-04-15T19:10In this episode, Jyoti D. Patel, MD, and Ani Balmanoukian, MD, discuss several studies investigating agents targeting TIGIT, an emerging immune checkpoint target with promising results in PD-L1-... Listen
Expert Answers to Key Questions on Current and Emerging BTK Inhibitor Therapies for CLL and MCL from 2022-03-31T21:15In this episode, Jeff P. Sharman, MD; Matthew S. Davids, MD, MMSc; and Anthony Mato, MD, MSCE, answer questions from a live CCO webinar on current best practices and emerging strategies in BTK ... Listen
Expert Insights on Optimal Current Management of Patients With Cholangiocarcinoma from 2022-03-21T18:00In this episode, Lipika Goyal, MD, leads an engaging discussion with Christine Chio, PharmD, BCOP, and Caroline Kuhlman, NP, on current treatment of patients with cholangiocarcinoma. Topics incl... Listen
Cancer Conversations: 3 Case Challenges of Real Patients With Myelodysplastic Syndromes from 2022-03-14T20:30In this podcast episode, Amy DeZern, MD, MHS, Daniel Pollyea, MD, MS, and Amer Zeidan, MBBS, discuss challenging cases in MDS, including
Expert Insights on Targeted Therapies for Advanced Systemic Mastocytosis from 2022-03-10T21:35In this episode, Dr Prithviraj Bose, Pharmacist Caitlin R. Rausch, and Nurse Practitioner Ilene A. Galinsky discuss incorporating KIT-targeted therapies into management of patients with advanced... Listen
Advances in B-Cell Lymphomas: Understanding Current Treatment Approaches from 2022-02-25T21:30In this episode, Julie M. Vose, MD, MBA; Brad S. Kahl, MD; and John P. Leonard, MD, discuss treatment approaches for patients with B-cell lymphomas, including information on:
TKIs for Advanced HCC in the Second Line and Beyond from 2022-02-22T17:00In this podcast episode from Clinical Care Options (CCO), Josep M. Llovet, MD, PhD, and Markus Peck-Radosavljevic, MD, MBA, discuss second line treatment of patients with advanced hepatocellular... Listen
New Directions With PARP Inhibitors in Pancreatic Cancer from 2022-02-21T18:35In this episode, Eileen M. O’Reilly, MD, and Naureen Starling, MD, FRCP, discuss emerging therapeutic strategies involving PARP inhibitor therapy in the treatment of pancreatic cancer. Topics i... Listen
Evolving Therapy for Myeloma: Experts Discuss Patient Case Examples from 2022-02-18T22:40In this episode,Brian G.M. Durie, MD; Thomas G. Martin, MD; Philippe Moreau, MD; S. Vincent Rajkumar, MD; and Jesús F. San-Miguel, MD, PhD, discuss treatment approaches for multiple myeloma usin... Listen
Precision Medicine for T-Cell Lymphomas: Expert Answers to Your Questions from 2022-01-31T22:30In this episode, Steven M. Horwitz, MD; Francine Foss, MD; and Barbara Pro, MD, answer questions from an audience of healthcare professionals on topics related to the management of patients with... Listen
Multidisciplinary Overview of EGFR-Mutated NSCLC: An Expert Panel Discussion From Biomarker Testing to Managing Progressive Disease from 2022-01-26T17:00In this podcast episode, Conor Ernst Steuer, MD, a medical oncologist; Frank Schneider, MD, a pathologist; and Elise Hitron, MSN, FNP-C, a phase I clinical trials nurse practitioner, engage in a... Listen
Experts Answer Questions on Current and Emerging Options for Hemophilia A Management from 2022-01-14T22:00
|